U.S. Paper and Forestry Products Stock News

Bath & Body Works recently reported its second-quarter 2025 results, showing sales of US$1,549 million and net income of US$64 million, while also completing a significant share buyback of over four million shares between May and August 2025. The company's updated earnings guidance for full-year 2025 now expects lower diluted earnings per share compared to 2024, accompanied by a slightly narrowed sales growth outlook. We'll explore how Bath & Body Works' earnings guidance revision and...

Last week, Unusual Machines, Inc. filed for a follow-on equity offering of 656,642 shares and presented at the H.C. Wainwright 27th Annual Global Investment Conference in New York. This combination of fresh capital-raising and direct engagement with the investment community spotlights the company's plans for funding expansion and broader market visibility. We'll explore how the recent equity offering reveals Unusual Machines' intentions to strengthen its capital base for anticipated...

Earlier this month, Zscaler, Inc. announced full-year results for the period ended July 31, 2025, highlighting annual sales of US$2.67 billion and a narrowing net loss of US$41.48 million, alongside the completion of the Red Canary acquisition. The company also issued upbeat revenue guidance for fiscal 2026 and reported accelerating adoption of its AI and Zero Trust security solutions among Global 2000 and Fortune 500 customers. We’ll now explore what Zscaler’s improved revenue outlook and...

Hamilton Lane (HLNE) just wrapped up a busy week, grabbing attention with two headlining moves. First, the firm completed a sizable follow-on equity offering, raising $77.5 million to help fuel its business strategy. Shortly after, Hamilton Lane launched its Global Private Secondary Fund, which nearly doubled its target at kickoff. This points to sharp investor appetite and reinforces the firm's knack for capital raising and product innovation. For investors weighing their next step, these...

In the past week, Allsteel, part of HNI (NYSE:HNI), opened its new Design Lab in Washington, D.C., featuring a hands-on, collaborative workspace created with Gensler D.C. and centered on evolving office design concepts. Meanwhile, a significant downward revision in U.S. nonfarm employment data from the Bureau of Labor Statistics has drawn attention to the potential for a softer economic outlook. While HNI continues to invest in workplace innovation and adaptive design, the revised employment...

Qorvo (QRVO) is catching investors’ eyes this week after reports surfaced detailing the company’s manageable net debt position alongside a sharp decline in its EBIT over the last year. The story here is a classic balancing act: on one hand, Qorvo’s ability to comfortably cover interest expenses signals there is no immediate debt threat; on the other, a 14% fall in EBIT has introduced new doubts about future earnings resilience and the durability of its balance sheet. For shareholders and...

In early September 2025, Elevance Health, Inc. completed several large fixed-rate unsecured note offerings with maturities ranging from 2028 to 2055, raising approximately US$2.25 billion and adding major investment banks as co-lead underwriters. This substantial fixed-income financing strengthens Elevance Health's liquidity position and signals an increased capacity for operational investment and financial flexibility despite recent earnings pressure. Next, we'll assess how Elevance...

Galaxy Digital Inc. recently announced a partnership with Superstate, enabling stockholders to tokenize and hold SEC-registered Galaxy Digital (GLXY) shares directly onchain via the Solana blockchain, marking the first time a public company has legally tokenized its equity on a major blockchain with full SEC compliance. This move could transform public equity infrastructure by allowing 24/7 trading, instant settlement, and direct onchain ownership for approved and KYC-verified...

If you're tracking Dianthus Therapeutics (DNTH), two events this week will have caught your eye. The company announced strongly positive results from its Phase 2 MaGic trial for claseprubart in adults with generalized myasthenia gravis, showing both statistically significant and clinically meaningful improvements with a favorable safety profile. Almost immediately, Dianthus followed up by completing a sizeable follow-on equity offering, adding over $250 million to its coffers for the next...

In recent days, ConocoPhillips and EQT Corporation each announced long-term agreements to purchase 1 million and 1.5 million tonnes per annum of LNG respectively from NextDecade’s Rio Grande LNG Train 5, with both deals contingent on a positive final investment decision and covering 20-year terms. This wave of agreements signals NextDecade’s substantive progress on commercializing its LNG infrastructure, underscored by its extension of engineering contract price validity and visibility at...

Earlier this month, Absolute Climate announced a partnership with Northern Trust to deliver a regulated, infrastructure-rich carbon credit issuance system, integrating third-party certification and digital lifecycle management for project developers and buyers through the Northern Trust Carbon Ecosystem™. This collaboration aims to address credibility and transparency in carbon markets by aligning rigorous, independent certification with regulated credit issuance, offering enhanced support...

Perella Weinberg Partners recently announced the appointment of David Wyles as Partner, based in London, to lead its UK and European businesses and provide strategic and financial advisory services across sectors. Wyles brings nearly three decades of high-level M&A and restructuring experience from Greenhill & Co., reflecting a move to strengthen the firm’s European expertise and leadership. We’ll explore how the addition of such a seasoned industry executive could influence Perella Weinberg...

Earlier this year, multiple law firms filed class action lawsuits against Flywire Corporation following its disclosure of disappointing financial results, lowered revenue guidance, and restructuring plans that included a workforce reduction of about 10%. A unique aspect of these lawsuits is the accusation that Flywire understated the negative business impacts of international permit and visa restrictions, especially in key education markets such as Canada and Australia. We'll now examine how...

Deciding what to do with Bristol-Myers Squibb stock right now might feel like a coin toss, but there is more than luck at play. The stock closed recently at $47.15, and if you have been watching the rollercoaster of news out of Washington and Brussels, you know the ride has been eventful. Over the past year, the share price has moved up just 1.6%, with more dramatic swings when you zoom out and in: it is down 17.0% year-to-date and has dropped 24.0% over the last three years. So what is...

ARS Pharmaceuticals (SPRY) is catching investor attention this week after sharing real-world clinical data that puts its flagship product, neffy, squarely in the spotlight. Unlike traditional epinephrine injections, neffy is a needle-free nasal spray aimed at treating anaphylaxis. The company announced that neffy demonstrated an 89.2% success rate in 545 patients, very close to what is seen with the tried-and-true injection method. The findings, now accepted for publication in a leading...

What’s Behind Viking Therapeutics' Recent Moves? If you hold shares of Viking Therapeutics (VKTX) or are thinking about jumping in, the stock’s roller-coaster ride this year is hard to ignore. With no single event triggering the latest price action, the subtle shifts in VKTX’s value are drawing attention. Investors are left wondering if the market is signaling something new about the company’s prospects or just recalibrating after a stretch of volatility. Even without a headline-grabbing...

On September 9, 2025, Cboe Global Markets announced plans to launch Cboe Continuous futures for bitcoin and ether on its U.S. futures exchange, pending regulatory review. This move introduces single, long-dated, cash-settled contracts with daily spot price alignment, aiming to simplify digital asset exposure and risk management for U.S. traders. We'll explore how the introduction of Cboe Continuous futures in digital assets could influence the long-term investment outlook for the company. AI...

Freddie Mac recently announced the pricing of its second Seasoned Credit Risk Transfer Trust (SCRT) offering of 2025, involving the securitization of about US$707 million in seasoned re-performing loans with both guaranteed senior and non-guaranteed subordinate securities. This securitization marks a significant move in Freddie Mac’s approach to managing less-liquid assets and mitigating credit and market risk in its investment portfolio. To assess the impact on Freddie Mac’s investment...

In recent days, analysts have shown strong agreement that Sezzle will report earnings surpassing previous estimates and have upgraded its ranking to reflect this optimism. This surge in analyst confidence highlights a growing belief in Sezzle's near-term financial outlook among investment professionals. We'll now explore what rising analyst optimism and stronger earnings expectations might mean for Sezzle's broader investment narrative. Trump's oil boom is here - pipelines are primed to...

Trying to figure out if now’s the right moment to buy, sell, or just sit tight with Amazon.com stock? You’re hardly alone. Amazon continues to draw the attention of investors, and with good reason. Over the past year, shares have popped by 24.8%. Looking farther back, a 79.2% gain in the last three years showcases the kind of long-term performance that keeps Amazon in the spotlight. More recent moves, including a 1.9% lift just in the last week, make it tough to ignore for those watching...

If you've been following Global-E Online (NasdaqGS:GLBE), you likely caught the news that the company’s Board just signed off on a share repurchase program worth up to $200 million. This program will be funded from cash on hand as well as future cash generated by the business. For investors, buybacks like this are always intriguing, as they often indicate that leadership feels the stock is undervalued or that they are confident about future prospects. It is not common for a growth-focused...

Playhouse MD™ announced a distribution alliance with McKesson Medical-Surgical, bringing its doctor-designed, kid-friendly medical devices to Amazon and expanding access to pediatric care solutions for families across the US. This marks the first time McKesson Medical-Surgical has included a play-based pediatric brand in its large portfolio, reflecting ongoing moves toward consumer-focused healthcare offerings. We'll explore how McKesson's entry into consumer pediatric devices via Amazon...

Webflow recently announced a new integration with Adobe Marketo Engage and showcased its expanded collaboration with Adobe Express at Adobe Summit 2025, bringing advanced AI-driven image creation and marketing personalization tools directly into the Webflow platform for marketing teams. This integration is designed to help marketers leverage audience data and generative AI-powered content creation to enhance website personalization and improve campaign optimization within a unified...

DocuSign recently reported its second quarter earnings, showing year-over-year revenue growth to US$800.64 million but a substantial drop in net income to US$62.97 million, along with updates to its board of directors and a completed share buyback tranche. The company’s new board appointments, including a CEO and seasoned finance executive as board chair, may signal shifts in governance and future strategic direction. We'll examine how DocuSign's weaker net income alongside governance...